Alexander Nowak
Stock Analyst at Craig-Hallum
(2.63)
# 2,241
Out of 5,022 analysts
45
Total ratings
44.44%
Success rate
6.38%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $9.30 | +136.56% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $172.81 | -9.15% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $6.70 | +153.73% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $26.17 | +117.81% | 6 | Sep 5, 2024 | |
| CELC Celcuity | Assumes: Buy | $25 → $27 | $46.20 | -41.56% | 2 | May 16, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $14.36 | +4.46% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $6.85 | +16.79% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $1.57 | +1,046.50% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $14.38 | +247.71% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $280 → $160 | $14.38 | +1,012.66% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $60.56 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.91 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $3.05 | +260.66% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $59.27 | +85.59% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $0.44 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $3.18 | +9,333.96% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $9.14 | +206.35% | 1 | Aug 31, 2020 |
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $9.30
Upside: +136.56%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $172.81
Upside: -9.15%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $6.70
Upside: +153.73%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $26.17
Upside: +117.81%
Celcuity
May 16, 2024
Assumes: Buy
Price Target: $25 → $27
Current: $46.20
Upside: -41.56%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $14.36
Upside: +4.46%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $6.85
Upside: +16.79%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $1.57
Upside: +1,046.50%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $14.38
Upside: +247.71%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $280 → $160
Current: $14.38
Upside: +1,012.66%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $60.56
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.91
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $3.05
Upside: +260.66%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $59.27
Upside: +85.59%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $0.44
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $3.18
Upside: +9,333.96%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $9.14
Upside: +206.35%